Characteristics of 56 Patients With Malignant Lymphoma
| Sex | |
| Male/female | 33/23 |
| Age | |
| Median (range) | 58 years (13 to 86 years) |
| Histology | |
| Non-Hodgkin's lymphoma | 48 |
| Low grade | 10 |
| Intermediate | 32 |
| High grade | 5 |
| Other | 1 |
| Hodgkin's disease | 8 |
| Immunophenotype | |
| B/T | 38/8 |
| Ann Arbor stage* | |
| I | 5 |
| II | 14 |
| III | 15 |
| IV | 22 |
| Performance status | |
| 0, 1 | 22 |
| 2, 3, 4 | 34 |
| B symptoms | |
| Absent | 29 |
| Present | 27 |
| Serum LDH level | |
| ≤1 × normal | 33 |
| >1 × normal | 23 |
| Hemoglobin | |
| ≤11g/dL | 22 |
| >11g/dL | 34 |
| International Prognostic Index* | |
| Low | 16 |
| Low intermediate | 9 |
| High intermediate | 5 |
| High | 17 |
| Sex | |
| Male/female | 33/23 |
| Age | |
| Median (range) | 58 years (13 to 86 years) |
| Histology | |
| Non-Hodgkin's lymphoma | 48 |
| Low grade | 10 |
| Intermediate | 32 |
| High grade | 5 |
| Other | 1 |
| Hodgkin's disease | 8 |
| Immunophenotype | |
| B/T | 38/8 |
| Ann Arbor stage* | |
| I | 5 |
| II | 14 |
| III | 15 |
| IV | 22 |
| Performance status | |
| 0, 1 | 22 |
| 2, 3, 4 | 34 |
| B symptoms | |
| Absent | 29 |
| Present | 27 |
| Serum LDH level | |
| ≤1 × normal | 33 |
| >1 × normal | 23 |
| Hemoglobin | |
| ≤11g/dL | 22 |
| >11g/dL | 34 |
| International Prognostic Index* | |
| Low | 16 |
| Low intermediate | 9 |
| High intermediate | 5 |
| High | 17 |
Patients were classified before MRI examination.